WHWK (Aadi Bio) Earnings per share growth rate in current year
Aadi Bioscience Inc (WHWK) profitability is based on the sales of FYARRO in oncology centers and the expansion of its application. The YoY earnings per share growth rate demonstrates a sustainable trend, where the current metric is -185.60. High margins are supported by albumin nanoparticles and the patent for PEComa treatment, while the orphan drug status creates a barrier for new entrants due to the high cost of testing.
Financial and market metric breakdowns for aadibio.com (WHWK)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
- earnings and market multiples details:
WHWK - Company Net Income|Expected Net Profit Aadi Bioscience Inc|WHWK - Price to Earnings Ratio|Market Cap to Projected Earnings Aadi Bioscience|WHWK - PEG Multiple|Enterprise Value to EBITDA Ratio WHWK|WHWK - Operating profit EBITDA|Net earnings per share for the last four quarters Aadi Bioscience|WHWK - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months aadibio.com|WHWK - Earnings per share growth in current year|Projected earnings per share growth rate for next year Aadi Bioscience Inc
Summary company analysis:Aadi Bio (WHWK)
Aadi Bioscience Inc (WHWK) utilizes an outsourcing model for development and production to minimize capital expenditures. This approach directly impacts the comparable year-over-year growth rate of earnings per share, which measures the dynamics of net income per share. This metric reflects the efficiency of operating expense management relative to previous periods. Analyzing the trajectory of this indicator allows for an assessment of the business's financial stability. Investors use this indicator to verify the scalability of the scientific model.
Direct competitors
BeiGene Ltd. - Earnings per share increase in current year|HALO (Halozyme Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Revolution Medicines Corp RVMD|Earnings growth in current year AAPG|Earnings growth in current year cgoncology.com (CGON)|Earnings growth in current year URGN (UroGen Pharma)|Earnings growth in current year Bicara Therapeutics Inc BCAX|Personalis Corp - Earnings growth in current year|ERAS (Erasca Oncology) - Earnings per share growth this year|DCTH: Earnings growth in current year|YMAB - Expected net earnings per share growth this year|Net earnings per share growth this year AURA|CADL: Earnings per share increase in current year|Earnings growth in current year ARAY|Earnings per share growth in current year SLS (sellaslifesciences.com)|Earnings growth in current year ACTU (Actuate Therapeutics, Inc.)|Expected net earnings per share growth this year citiusonc.com (CTOR)|HURA - Earnings per share growth in current year|Earnings per share growth rate in current year Protara Therapeutics Inc|Fate Therapeutics Corp (FATE) - Earnings per share growth in current year|TCRX - Expected net earnings per share growth this year|CSBR (Champions Oncology Inc) - Earnings growth in current year|Net earnings per share growth this year XBiotech USA (XBIT)|Earnings growth in current year CVM|Expected net earnings per share growth this year OS Therapies Inc.|Earnings growth in current year RADX (Radiopharm Theranostics)|Artiva Biotherapeutics Inc. (ARTV) - Earnings per share growth rate in current year|ANL - Earnings per share growth in current year|VERU (verupharma.com) - Earnings per share growth this year|TPST: Earnings growth in current year|Net earnings per share growth this year Xilio Therapeutics|RENB (Renovaro Biosciences) - Earnings growth in current year|Earnings per share growth rate in current year Mural Bio MURA|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|OKUR (onkuretherapeutics.com) - Earnings per share increase in current year|Earnings growth in current year GDTC (CytoMed Therapeutics Limited)|Expected net earnings per share growth this year Curis Inc. (CRIS)|APLM - Earnings per share growth in current year|THAR (Tharimmune Corporation) - Earnings per share growth this year|ADVB: Earnings growth in current year|Net earnings per share growth this year genprex.com|Net earnings per share growth this year CLDI|Net earnings per share growth this year sunshinebiopharma.com (SBFM)|Earnings growth in current year XBIO|SLRX (Salarius Pharma) - Earnings per share increase in current year|Purple Biotech - Net earnings per share growth this year|AONC - Net earnings per share growth this year|BGNE - Earnings per share growth in current year|CKPT - Earnings growth in current year|ELEV: Earnings growth in current year|Net earnings per share growth this year iCAD|IKNA (Ikena Oncology Inc.) - Earnings growth in current year|Earnings growth in current year notablelabs.com|Earnings per share growth in current year Viracta Therapeutics (VIRX)|MorphoSys Inc - Earnings per share growth this year|Earnings growth in current year NAYA (NAYA Bio)|AAPGV - Net earnings per share growth this year
